Incannex doses first patient in Phase 2 DReAMzz trial of IHL-42XAug 25Regulatory milestoneIHL-42XIncannex Healthcare Ltd
SciSparc's NeuroThera launches Tourette syndrome trial site at YaleAug 5Clinical readoutSciSparc Ltd.
SciSparc's NeuroThera opens German Phase IIb site for Tourette drug SCI-110Jul 15Clinical readoutSciSparc Ltd.
Sign inSign in